News | August 21, 2024
Procter & Gamble Health reports Q4 sales at Rs. 277 Cr
The company recorded sales of Rs. 1,129 crore for the fiscal year ended June 30, 2024,
The company recorded sales of Rs. 1,129 crore for the fiscal year ended June 30, 2024,
The increase in PAT is driven by higher sales and lower marketing and depreciation charge vs the same period last year
The formulation contains 0.075% Capsaicin, a clinically proven ingredient along with menthol, camphor and eucalyptus oil
Records the largest number of videos of people saying the same sentence uploaded to Facebook in one hour to raise awareness on Iron Deficiency Anaemia
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
